SHARE

Pfizer completes Haleon exit

The pharmaceutical company has raised £2.5bn by offloading its remaining 7.3% stake in Haleon, which owns Panadol and Sensodyne. Some £170m of the £2.5bn was achieved through a buy back of shares by Haleon.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.